ovarian cancer decisions: treatment versus maintenance
Published 6 years ago • 573 plays • Length 4:52Download video MP4
Download video MP3
Similar videos
-
5:42
ovarian cancer: factors in deciding on maintenance therapy
-
26:02
updates in ovarian cancer: frontline maintenance
-
3:40
paola-1: combination maintenance therapy in ovarian cancer
-
1:49
dr. chon on challenges with maintenance therapy in ovarian cancer
-
7:56
maintenance therapy in ovarian cancer
-
3:23
case 1: observation versus maintenance therapy in ovarian cancer
-
7:09
biomarker-driven frontline ovarian cancer treatment
-
7:38
parp maintenance therapy in recurrent ovarian cancer
-
3:09
maintenance therapy for recurrent advanced ovarian cancer
-
6:31
prima: frontline niraparib maintenance therapy in ovarian cancer
-
4:17
maintenance therapy in ovarian cancer: parp inhibitors
-
6:25
niraparib maintenance therapy for ovarian cancer
-
44:10
ovarian cancer maintenance therapies
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
1:48
dr. secord on using biomarkers to guide treatment decisions in ovarian cancer
-
1:13:10
the state of ovarian cancer: exploring the landscape of systemic therapy
-
2:38
what is maintenance treatment for ovarian cancer?
-
7:24
ovarian cancer: maintenance following frontline bevacizumab
-
1:01
'maintenance treatment' could delay or prevent ovarian cancer recurrence